Save time and get answers to complex questions with AI chat
The expiration date of the key patent for guselkumab?Dabrafenib and trametinib cost?Patent expiry trametinib?Drugpatentwatch trametinib?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?
See the DrugPatentWatch profile for dalvance
Dalvance (dalbavancin) is an antibiotic used to treat certain serious bacterial skin and skin structure infections in adults. It’s prescribed when the infection is caused by susceptible bacteria and can be given as a long-acting, single- or two-dose course depending on the infection type and severity. [1]
Dalvance is used for skin and soft-tissue infections where bacteria are the cause, including cases classified as skin and skin structure infections. The exact eligibility depends on the organism suspected or confirmed and how severe the infection is. [1]
Dalvance is often considered when clinicians want fewer doses than typical daily antibiotic regimens for skin infections. That approach can help reduce the need for prolonged IV antibiotic schedules in some treatment settings. [1]
Dalvance is indicated for specific types of bacterial skin and skin structure infections in adults, not general uses like strep throat or urinary tract infections. If an infection is outside the labeled indication, clinicians use a different antibiotic based on the condition and likely bacteria. [1] Sources [1] https://www.drugpatentwatch.com/p/drug/dalvance/
Other Questions About Dalvance :